Baird Upgrades ResMed (RMD) to Outperform
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $226.99 -0.6%
Rating Summary:
12 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 27 | New: 11
Rating Summary:
12 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 27 | New: 11
Join SI Premium – FREE
Baird analyst Mike Polark upgraded ResMed (NYSE: RMD) from Neutral to Outperform with a price target of $300.00 (from $270.00).
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $244.17 yesterday.
You May Also Be Interested In
- New Street Research Upgrades AMD (AMD) to Buy
- BMO Capital Upgrades Magna Int'l (MGA) to Outperform
- Hubbell (HUBB) PT Raised to $238 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
